Travere-TxTM-Inline-fullcolor.png
Travere Therapeutics to Report Third Quarter 2024 Financial Results
October 21, 2024 16:30 ET | Travere Therapeutics, Inc.
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2024 financial results on Thursday, October 31, 2024, before the...
gcm.jpg
GCM Grosvenor Reports Third Quarter 2023 Earnings Results
November 08, 2023 08:00 ET | GCM Grosvenor
CHICAGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG) today reported its results for the third quarter 2023, which have been posted to the Public Shareholders section of GCM...
Syneos Health_rgb_r.jpg
Syneos Health Reports Third Quarter 2022 Results
November 04, 2022 06:10 ET | Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health_rgb_r.jpg
Syneos Health Reports Third Quarter 2021 Results
November 03, 2021 06:16 ET | Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Rackspace-Technology-Logo_Black-Aspect-640.png
Rackspace Technology to Announce Third Quarter 2021 Earnings on Monday, November 15, 2021
October 21, 2021 17:12 ET | Rackspace Technology, Inc.
SAN ANTONIO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, today announced that it will release its third...
Syneos Health_rgb_r.jpg
Syneos Health Schedules Third Quarter 2021 Earnings Call for Wednesday, November 3rd, 2021
October 19, 2021 09:32 ET | Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2021 financial...